BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 9916878)

  • 1. Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice.
    Hiremath MM; Saito Y; Knapp GW; Ting JP; Suzuki K; Matsushima GK
    J Neuroimmunol; 1998 Dec; 92(1-2):38-49. PubMed ID: 9916878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional differences between grey and white matter in cuprizone induced demyelination.
    Gudi V; Moharregh-Khiabani D; Skripuletz T; Koutsoudaki PN; Kotsiari A; Skuljec J; Trebst C; Stangel M
    Brain Res; 2009 Aug; 1283():127-38. PubMed ID: 19524552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cuprizone model: regional heterogeneity of pathology.
    Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L
    APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination.
    Skripuletz T; Hackstette D; Bauer K; Gudi V; Pul R; Voss E; Berger K; Kipp M; Baumgärtner W; Stangel M
    Brain; 2013 Jan; 136(Pt 1):147-67. PubMed ID: 23266461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphotoxin beta receptor (Lt betaR): dual roles in demyelination and remyelination and successful therapeutic intervention using Lt betaR-Ig protein.
    Plant SR; Iocca HA; Wang Y; Thrash JC; O'Connor BP; Arnett HA; Fu YX; Carson MJ; Ting JP
    J Neurosci; 2007 Jul; 27(28):7429-37. PubMed ID: 17626203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression in brain during cuprizone-induced demyelination and remyelination.
    Morell P; Barrett CV; Mason JL; Toews AD; Hostettler JD; Knapp GW; Matsushima GK
    Mol Cell Neurosci; 1998 Nov; 12(4-5):220-7. PubMed ID: 9828087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yokukansan Reduces Cuprizone-Induced Demyelination in the Corpus Callosum Through Anti-inflammatory Effects on Microglia.
    Nomura T; Bando Y; You H; Tanaka T; Yoshida S
    Neurochem Res; 2017 Dec; 42(12):3525-3536. PubMed ID: 28929408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative temporal changes in DTI values coupled with histological properties in cuprizone-induced demyelination and remyelination.
    Yano R; Hata J; Abe Y; Seki F; Yoshida K; Komaki Y; Okano H; Tanaka KF
    Neurochem Int; 2018 Oct; 119():151-158. PubMed ID: 29030079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.
    Skripuletz T; Lindner M; Kotsiari A; Garde N; Fokuhl J; Linsmeier F; Trebst C; Stangel M
    Am J Pathol; 2008 Apr; 172(4):1053-61. PubMed ID: 18349131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination.
    Tanaka T; Murakami K; Bando Y; Yoshida S
    J Neurochem; 2013 Oct; 127(2):259-70. PubMed ID: 23647102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous administration of human embryonic stem cell-derived neural precursor cells attenuates cuprizone-induced central nervous system (CNS) demyelination.
    Crocker SJ; Bajpai R; Moore CS; Frausto RF; Brown GD; Pagarigan RR; Whitton JL; Terskikh AV
    Neuropathol Appl Neurobiol; 2011 Oct; 37(6):643-53. PubMed ID: 21276029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.
    Steelman AJ; Thompson JP; Li J
    Neurosci Res; 2012 Jan; 72(1):32-42. PubMed ID: 22015947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of minocycline on cuprizone induced cortical demyelination.
    Skripuletz T; Miller E; Moharregh-Khiabani D; Blank A; Pul R; Gudi V; Trebst C; Stangel M
    Neurochem Res; 2010 Sep; 35(9):1422-33. PubMed ID: 20544279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocyte-targeted production of interleukin-6 reduces astroglial and microglial activation in the cuprizone demyelination model: Implications for myelin clearance and oligodendrocyte maturation.
    Petković F; Campbell IL; Gonzalez B; Castellano B
    Glia; 2016 Dec; 64(12):2104-2119. PubMed ID: 27535761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of microglial ablation and mesenchymal stem cell transplantation on a cuprizone-induced demyelination model.
    Tahmasebi F; Pasbakhsh P; Barati S; Madadi S; Kashani IR
    J Cell Physiol; 2021 May; 236(5):3552-3564. PubMed ID: 32996165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the CSF1R inhibitor PLX3397 on remyelination of corpus callosum in a cuprizone-induced demyelination mouse model.
    Tahmasebi F; Pasbakhsh P; Mortezaee K; Madadi S; Barati S; Kashani IR
    J Cell Biochem; 2019 Jun; 120(6):10576-10586. PubMed ID: 30628737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
    Acs P; Komoly S
    Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocyte ablation induced by La-aminoadipate (L-AAA) potentiates remyelination in a cuprizone demyelinating mouse model.
    Madadi S; Pasbakhsh P; Tahmasebi F; Mortezaee K; Khanehzad M; Boroujeni FB; Noorzehi G; Kashani IR
    Metab Brain Dis; 2019 Apr; 34(2):593-603. PubMed ID: 30652255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.
    Esser S; Göpfrich L; Bihler K; Kress E; Nyamoya S; Tauber SC; Clarner T; Stope MB; Pufe T; Kipp M; Brandenburg LO
    Mol Neurobiol; 2018 Aug; 55(8):6237-6249. PubMed ID: 29288338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel flavanone derivative ameliorates cuprizone-induced behavioral changes and white matter pathology in the brain of mice.
    Sun ZY; Gu HS; Chen X; Zhang L; Li XM; Zhang JW; Li L
    Psychiatry Res; 2017 Nov; 257():249-259. PubMed ID: 28783571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.